Protalix Biotherapeutics, Inc. (PLX)

1.78 +0.03 (+1.71%) USD  |  NYAM  |  Dec 24, 12:59
1.785 0.00 (0.00%) After-Hours: 13:59
More

Protalix Biotherapeutics SG&A Expense (TTM): 11.16M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for PLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
PAVmed, Inc. 16.57M
AIM ImmunoTech, Inc. 10.06M
Perspective Therapeutics, Inc. 31.53M
Electromed, Inc. 40.21M
Armata Pharmaceuticals, Inc. 12.31M